Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis. Prosperini L, De Angelis F, De Angelis R, Fanelli F, Pozzilli C J Neurol Neurosurg Psychiatry. 2014 Apr 30. PMID: 24790213. Abstract CommentRecommendBookmarkWatch